Degradation of endocannabinoids in chronic migraine and medication overuse headache
Chronic migraine (CM) is frequently associated with medication overuse headache (MOH). The endocannabinoid system plays a role in modulating pain including headache and is involved in the common neurobiological mechanism underlying drug addiction and reward system. Anandamide (AEA) and 2-arachidonoy...
Main Authors: | L.M. Cupini, C. Costa, P. Sarchielli, M. Bari, N. Battista, P. Eusebi, P. Calabresi, M. Maccarrone |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2008-05-01
|
Series: | Neurobiology of Disease |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0969996108000065 |
Similar Items
-
The journey from genetic predisposition to medication overuse headache to its acquisition as sequela of chronic migraine
by: Paolo Martelletti
Published: (2018-01-01) -
Treatment of withdrawal headache in patients with medication overuse headache: a pilot study
by: Sabina Cevoli, et al.
Published: (2017-05-01) -
Medication-overuse headache. Retrospective comparison of preventive treatments
by: Abouch V. Krymchantowski, et al. -
OnabotulinumtoxinA: An Effective Tool in the Therapeutic Arsenal for Chronic Migraine With Medication Overuse
by: Edoardo Caronna, et al.
Published: (2018-10-01) -
Medication-Overuse Headache: Differences between Daily and Near-Daily Headache Patients
by: Abouch V. Krymchantowski, et al.
Published: (2016-08-01)